Remove 2025 Remove Patient Care Remove Pharmaceutical Companies
article thumbnail

Pharma’s use of synthetic biology could deliver radical innovation

pharmaphorum

My SynBioBeta panel discussion was about the shape of biopharma in 2025 – a seemingly futuristic time that’s now less than four years away. Tanja Dowe is the CEO of Debiopharm Innovation Fund, the strategic investment arm of the Swiss pharmaceutical company Debiopharm. Funding radical innovation. About the interviewee.

article thumbnail

Health Data Management: Everything You Need to Know

Viseven

Source: Deloitte Combining these types of health data allows pharmaceutical companies to understand a person’s health and genetic profile better, thereby improving the quality of healthcare products and services. Pharma companies deal with enormous amounts of health data. What Is Health Data Management?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

APPE Rotation with PQA

PQA

Applications for the 2025-26 year are now being accepted. While I don't know what avenue I will choose immediately post-graduation, I plan to continue impacting patient care and improving health outcomes as a prominent leader within the specialty pharmacy field in five years. You can apply here.

article thumbnail

Influence of 5G on Healthcare

Viseven

Although 5G is currently limited to large cities in developed countries, by around 2025, we can expect its reach will extend beyond the urban areas. Pharmaceutical companies Pharmaceutical companies can transform their approaches to clinical trials with the help of 5G networks.

article thumbnail

How could tariffs impact the pharmaceutical industry?

European Pharmaceutical Review

Recent proposals by the US government to impose tariffs on pharmaceutical imports from key trade partners including the EU, China, India, Canada, and Mexico have raised concerns about market instability. 1 Here, we explore the potential impact of tariffs on pharmaceutical supply chains, pricing, investment and industry strategy.

article thumbnail

How Has Patient Marketing Changed in the Digital Age?

Pharma Marketing Network

This article dives deep into how patient marketing has changed, whats driving this transformation, and what strategies are leading the way for 2025 and beyond. Pharma marketers must adapt by embracing digital innovation, prioritizing personalization, and aligning with both patient expectations and compliance standards.

HIPAA 52